Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stichtenoth, D. O.
Right arrow Articles by Frolich, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stichtenoth, D. O.
Right arrow Articles by Frolich, J. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 37, 246-257, Copyright © 1998 by British Society for Rheumatology


REVIEWS

Nitric oxide and inflammatory joint diseases

DO Stichtenoth and JC Frolich
Department of Clinical Pharmacology, Hannover Medical School, Germany.

Nitric oxide (NO) is synthesized from L-arginine by the NO synthases. At present, mainly three NO synthase isoenzyme groups are differentiated: two constitutive NO synthases, responsible for homeostatic cardiovascular and neuronal functions of NO, and an inducible NO synthase. After induction by certain cytokines or endotoxin, this latter isoform produces large quantities of NO with cyto- and bacteriotoxic effects. High amounts of NO, synthesized systemically and intra-articularly, play an important role in inflammatory joint diseases, as shown in animal models of arthritis and in patients with rheumatoid arthritis or spondyloarthropathies. In experimental arthritis, administration of NO synthase inhibitors profoundly reduced disease activity. In humans, beneficial effects of NO synthesis inhibition are inferred from indirect evidence: glucocorticoids, inhibiting induction of the inducible NO synthase, reduce enhanced NO synthesis and disease activity. Thus, selective inhibition of the pathologically enhanced NO synthesis emerges as a new experimental therapeutic approach in the treatment of inflammatory joint diseases.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Pilon, P. Dallaire, and A. Marette
Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase: A NEW MECHANISM OF ACTION OF INSULIN-SENSITIZING DRUGS
J. Biol. Chem., May 14, 2004; 279(20): 20767 - 20774.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Jaramillo, P. H. Naccache, and M. Olivier
Monosodium Urate Crystals Synergize with IFN-{gamma} to Generate Macrophage Nitric Oxide: Involvement of Extracellular Signal-Regulated Kinase 1/2 and NF-{kappa}B
J. Immunol., May 1, 2004; 172(9): 5734 - 5742.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J U Kim, H K Chang, S S Lee, J W Kim, K T Kim, S W Lee, and W T Chung
Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis
Ann Rheum Dis, November 1, 2003; 62(11): 1083 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
H Yki-Jarvinen, R Bergholm, and M Leirisalo-Repo
Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis
Ann Rheum Dis, July 1, 2003; 62(7): 630 - 634.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
Y Ersoy, E Ozerol, O Baysal, I Temel, R S MacWalter, U Meral, and Z E Altay
Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis
Ann Rheum Dis, January 1, 2002; 61(1): 76 - 78.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. McMillan, M. Adler, D. S. Auld, J. J. Baldwin, E. Blasko, L. J. Browne, D. Chelsky, D. Davey, R. E. Dolle, K. A. Eagen, et al.
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry
PNAS, February 15, 2000; 97(4): 1506 - 1511.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Gassner, M. J. Buckley, H. Georgescu, R. Studer, M. Stefanovich-Racic, N. P. Piesco, C. H. Evans, and S. Agarwal
Cyclic Tensile Stress Exerts Antiinflammatory Actions on Chondrocytes by Inhibiting Inducible Nitric Oxide Synthase
J. Immunol., August 15, 1999; 163(4): 2187 - 2192.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Nicholson, C. K. Manner, J. Kleeman, and C. L. MacLeod
Sustained Nitric Oxide Production in Macrophages Requires the Arginine Transporter CAT2
J. Biol. Chem., May 4, 2001; 276(19): 15881 - 15885.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.